Sort
326,823 grants matching “clinical trial”
CoVPN 3005: Efficacy, Immunogenicity, and Safety of Two SARS-CoV-2 Recombinant Protein Vaccines with Adjuvant in Adults 18 Years of Age and Older - LC 3
$3,544,100Margaret Juliana McElrath · Fred Hutchinson Cancer Center · UM1 · FY2022 · AI
Childhood Cancer Survivor Study
$3,543,250Gregory Armstrong · St. Jude Children'S Research Hospital · U24 · FY2021 · CA
The AYA-RISE Intervention: Risk Information and Screening Education for Adolescents and Young Adults with Cancer Predisposition Syndromes
$3,543,148Jennifer W Mack · Dana-Farber Cancer Inst · U01 · FY2019 · CA
Development of rationally designed HIV vaccines
$3,542,953Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Addressing the chronic pain epidemic among older adults in underserved community center; The GetActive+ study.
$3,542,451Ana-Maria Vranceanu · Massachusetts General Hospital · R33 · FY2024 · AG
Development of a recombinant trimeric RSV-F vaccine (DS-Cav1)
$3,542,377Frank Arnold · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Utah Center for Clinical and Translational Science
$3,542,367Rachel Hess · University Of Utah · UL1 · FY2019 · TR
COG NCTN Network Group Operations Center - Year 10 Administrative Supplements
$3,541,929Douglas S. Hawkins · Public Health Institute · U10 · FY2023 · CA
Boston HIV CTU
$3,541,665Daniel R Kuritzkes · Brigham And Women'S Hospital · UM1 · FY2024 · AI
Cancer Center Support Grant P30
$3,540,688Primo N Lara · University Of California At Davis · P30 · FY2022 · CA
Improving Clinical trial Education, Recruitment, and Enrollment at CTSA Hubs (I-CERCH)
$3,539,629Paul A. Harris · Vanderbilt University Medical Center · U24 · FY2018 · TR
Novel, Non-Opioid, Non-Addictive Intrathecal Therapy for the Treatment of Chronic Pain
$3,539,507James N Campbell · Centrexion Therapeutics Corporation · UH3 · FY2024 · NS
Utah Trial Innovation Center
$3,539,199Jonathan Michael Dean · University Of Utah · U24 · FY2018 · TR
THERAPY OF CML
$3,538,057University Of Texas Md Anderson Can Ctr · P01 · FY2005 · CA
CONCERT-Clinical Effectiveness Research (CONCERT-CER)
$3,537,987Edward T Naureckas · University Of Chicago · RC2 · FY2010 · HL
DCTD Cancer Imaging
$3,537,972David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2014 · CA
Coordinating Center for Organ Transplant Clinical Trials (U01)
$3,537,949David N. Ikle · Rho Federal Systems Division, Inc. · U01 · FY2010 · AI
WISDOM: A platform to optimize subtype-specific screening and prevention
$3,537,456Laura J Esserman · University Of California, San Francisco · P01 · FY2024 · CA
Biology of Long-Term Mechanical Circulatory Support
$3,537,329Columbia University Health Sciences · P50 · FY2005 · HL
The Therapy of CML
$3,537,028Richard E. Champlin · University Of Tx Md Anderson Can Ctr · P01 · FY2012 · CA
Epidemiology of Diabetes Interventions and Complications Data Coordinating Center
$3,535,377John M Lachin · George Washington University · U01 · FY2012 · DK
Molecular and Clinical Manifestations of Matrix and Aggregate Myopathies
$3,535,200Carsten Bonnemann · National Institute Of Neurological Disorders And Stroke · ZIA · FY2018 · NS
RCT OF PLANT-BASED DIET IN BREAST CANCER RECURRENCE
$3,535,076University Of California San Diego · R01 · FY2004 · CA
NATIENS: A Phase III Randomized Double Blinded Study to Determine the Mechanisms and Optimal Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
$3,535,017Elizabeth Phillips · Vanderbilt University Medical Center · U01 · FY2021 · AI
Pterygopalatine Fossa (PPF) Block as an Opioid Sparing Treatment for AcuteHeadache in Aneurysmal Subarachnold Hemorrhage
$3,534,431Katharina Maria Busl · University Of Florida · U01 · FY2024 · NS